A LOOK AT HOW
PSYCHEDELIC CANADA
MAGAZINE
IS CHANGING THE WORLD BY XANDER LANDRY
Cybin Inc.is a company that’s focused on integra ng psychedelics and therapeu cs by engineering innova ve drug delivery systems and treatment regimens for mental health disorders. Founded in 2019, Cybin Corp has quickly become a leading force in the industry by crea ng safe and effec ve psychedelic therapeu cs for pa ents to help address a variety of mental health issues. Cybin is dedicated to helping the world through psychedelics. With its headquarters in Canada Cybin Corp reaches both here and abroad with opera ons in the USA, UK, and Ireland. With over a dozen patent filings that cover a range of novel psychedelic compounds of different classes such as Duetrated Psilocybin and Duerated Tryptamine. This leads to mul ple studies being conducted on the effects and applica ons of these compounds and many posi ve results in trea ng therapy-resistant disorders such as addic on, depression, and PTSD.
Partnering with companies like Kernel with its Flow technology used for the real- me non-invasive recording of brain ac vity, as well as collaborating with Greenbrook on building mental health centres of excellence for the research and development of innova ve psychedelic compound based therapeu cs for pa ents suffering from treatment-resistant depression.
With psychedelics in the spotlight more than ever and the nega ve s gma of a controlled substance looming over coming to an end, posi ve companies that put pa ents first like Cybin Corp are what we need to help lead the way to psychedelics’ full medical poten al.
www.psychedeliccanada.net
44
